NCT02777827View on ClinicalTrials.gov

A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 21, 2016

Primary Completion Date

November 29, 2016

Study Completion Date

November 29, 2016

Conditions
Asthma
Interventions
DRUG

Abediterol 0.156 μg

Dry powder for inhalation

DRUG

Abediterol 2.5 μg

Dry powder for inhalation

DRUG

Abediterol 0.05 μg

Pressurised metered-dose inhaler

DRUG

Abediterol 0.156 μg

Pressurised metered-dose inhaler

DRUG

Abediterol 2.5 μg

Pressurised metered-dose inhaler

OTHER

Placebo

Pressurised metered-dose inhaler and dry powder for inhalation.

Trial Locations (4)

14050

Research Site, Berlin

22927

Research Site, Großhansdorf

23552

Research Site, Lübeck

65187

Research Site, Wiesbaden

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT02777827 - A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma | Biotech Hunter | Biotech Hunter